Weaver Capital Management LLC Acquires 84 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Weaver Capital Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 4,285 shares of the healthcare conglomerate’s stock after purchasing an additional 84 shares during the period. Weaver Capital Management LLC’s holdings in UnitedHealth Group were worth $2,168,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. M&T Bank Corp lifted its stake in shares of UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. raised its stake in shares of UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new position in UnitedHealth Group in the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC lifted its stake in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently issued reports on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Finally, Wells Fargo & Company lowered their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $545.08 on Wednesday. The business has a fifty day simple moving average of $535.03 and a 200 day simple moving average of $565.09. The company has a market cap of $501.63 billion, a P/E ratio of 35.17, a P/E/G ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the firm earned $5.83 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.